BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36876163)

  • 21. Corrigendum to "Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study" [Phys. Imaging Radiat. Oncol. 22 (2022) 131-136].
    Saltybaeva N; Tanadini-Lang S; Vuong D; Burgermeister S; Mayinger M; Bink A; Andratschke N; Guckenberger M; Bogowicz M
    Phys Imaging Radiat Oncol; 2022 Jul; 23():43. PubMed ID: 35783579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum to ‛Effects of a mouth-opening intervention with remote support on adherence, the maximum interincisal opening, and mandibular function of postoperative oral cancer patients: A randomized clinical trial' [Eur. J. Oncol. Nurs. 40 (2019) 111-119].
    Wang TJ; Su JH; Leung KW; Liang SY; Wu SF; Wang HM
    Eur J Oncol Nurs; 2019 Aug; 41():195. PubMed ID: 31358252
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Aiming for a holistic integrated service for men diagnosed with prostate cancer - Definitions of standards and skill sets for nurses and allied healthcare professionals" [Eur. J. Oncol. Nurs. 29 (2017) 31-38].
    Lamb AD; Thompson S; Kinsella N; Gerbitz I; Chapman E; Putt L; Bennett S; Thankappannair V; Geoghegan L; Wright N; Stirton-Croft A; Nixon P; Styling A; Whitney D; Hodgson L; Punt L; Longmore J; Carter M; Petch B; Rimmer Y; Russell S; Hughes-Davies L; Mazhar D; Shah NC; Gnanapragasam VJ; Doble A; Bratt O; Kastner C
    Eur J Oncol Nurs; 2017 Oct; 30():59. PubMed ID: 29031314
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Co-existent abdominoperitoneal tuberculosis with endometrial cancer: A diagnostic and surgical challenge" [Gynecol. Oncol. Rep. 37 (2021) 100848].
    Ashraf M; Goh WA; Tan EMX; Nadarajah R
    Gynecol Oncol Rep; 2021 Nov; 38():100861. PubMed ID: 34977315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corrigendum to "Harmonization of breast cancer radiotherapy treatment planning in the Netherlands" [Tech. Innov. Patient Support Radiat. Oncol. 19 (2021) 26-32].
    Hurkmans C; Duisters C; Peters-Verhoeven M; Boersma L; Verhoeven K; Bijker N; Crama K; Nuver T; van der Sangen M
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100196. PubMed ID: 36659912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum to "Effects of an interactive coaching intervention on quality of life and psychological factors for colorectal cancer survivors: A single group pre and posttest design" [Eur. J. Oncol. Nurs. 66C (2023) 102413].
    Yoon J; Lee H; Son H
    Eur J Oncol Nurs; 2023 Dec; 67():102454. PubMed ID: 37968148
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to: ``The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.'' J Bone Oncol. 2020 Feb; 20: 100271.
    Richert I; Gomez-Brouchet A; Bouvier C; Du Bouexic De Pinieux G; KaranianM A; Blay JY; Dutour A
    J Bone Oncol; 2020 Jun; 22():100287. PubMed ID: 32274326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648].
    Oh J; Barve M; Senzer N; Aaron P; Manning L; Wallraven G; Bognar E; Stanbery L; Horvath S; Manley M; Nemunaitis J; Walter A; Rocconi RP
    Gynecol Oncol Rep; 2021 May; 36():100740. PubMed ID: 34095420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corrigendum to "Bereavement stressors and psychosocial well-being of young adults following the loss of a parent - A cross-sectional survey" [Eur. J. Oncol. Nurs. 35 (2018) 33-38].
    Lundberg T; Forinder U; Olsson M; Fürst CJ; Årestedt K; Alvariza A
    Eur J Oncol Nurs; 2019 Jun; 40():1. PubMed ID: 31229197
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to "Why should radiation oncology do translational research?" [Rep Pract Oncol Radiother 2019;24(1):60-64].
    Cañas R; Linares I; Guedea F; Berenguer Francés MÁ
    Rep Pract Oncol Radiother; 2019; 24(2):151. PubMed ID: 30723386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corrigendum to "Surface-guided radiotherapy for lung cancer can reduce the number of close patient contacts without compromising initial setup accuracy" [Tech. Innov. Patient Support Radiat. Oncol. 20 (2021) 61-63].
    Blake N; Pereira L; Eaton DJ; Dobson D
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100197. PubMed ID: 36659911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corrigendum to "Two compound techniques for total body irradiation" [Tech. Innov. Patient Support Radiat. Oncol. 21 (2022) 1-7].
    Hansen AT; Rose HK; Yates ES; Hansen J; Petersen JBB
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100199. PubMed ID: 36659910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corrigendum to "Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation" [Gynecol. Oncol. Rep. 22 (2017) 9-12].
    Martin M; Grisham RN; Turashvili G; Halpenny DF; Aghajanian CA; Makker V
    Gynecol Oncol Rep; 2017 Nov; 22():118. PubMed ID: 29296657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum to "Metastatic hepatoid carcinoma of ovarian origin - A case report from Northern Pakistan" [Gynecol. Oncol. Rep. 21 (2017) 24-27].
    Mahmood H; Fatima H; Faheem M
    Gynecol Oncol Rep; 2017 Nov; 22():117. PubMed ID: 29296656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum to "Challenges in the transition to independent radiation oncology practice and targeted interventions for improvement" [Tech. Innov. Patient Support Radiat. Oncol. 24 (2022) 113-117].
    De Leo AN; Drescher N; Bates JE; Yeung AR
    Tech Innov Patient Support Radiat Oncol; 2023 Mar; 25():100202. PubMed ID: 36873801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corrigendum to "Potential pre-COPD indicators in association with COPD development and COPD prediction models in Chinese: a prospective cohort study" [The Lancet Regional Health - Western Pacific 44 (2024) 100984].
    Fan J; Fang L; Cong S; Zhang Y; Jiang X; Wang N; Chen Y
    Lancet Reg Health West Pac; 2024 Mar; 44():101033. PubMed ID: 38333896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimising Radiation Therapy Dose to the Swallowing Organs at Risk: An In Silico Study of feasibility for Patients with Oropharyngeal Tumours.
    Barnhart MK; Cartmill B; Ward EC; Brown E; Sim J; Saade G; Rayner S; Robinson RA; Simms VA; Smee RI
    Dysphagia; 2019 Dec; 34(6):869-878. PubMed ID: 30741335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.
    Katz H; Wassie E; Alsharedi M
    Med Oncol; 2017 Sep; 34(10):170. PubMed ID: 28864844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum to "Association of high cortisol levels in pregnancy and altered fetal growth. Results from the MAASTHI, a prospective cohort study, Bengaluru" [The Lancet Regional Health - Southeast Asia 14 (2023) 100196].
    Shriyan P; Sudhir P; van Schayck OCP; Babu GR
    Lancet Reg Health Southeast Asia; 2024 May; 24():100374. PubMed ID: 38756157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Errata.
    J Hand Surg Glob Online; 2021 Nov; 3(6):373-374. PubMed ID: 35420757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.